Detalles de la búsqueda
1.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Hepatology
; 75(1): 219-228, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537988
2.
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
BMC Public Health
; 22(1): 1385, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35854275
3.
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
BMC Public Health
; 23(1): 923, 2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217864
4.
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
J Antimicrob Chemother
; 71(7): 1987-93, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994089
5.
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
J Antimicrob Chemother
; 71(7): 1982-6, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994091
6.
Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial.
Clin Infect Dis
; 60(5): 811-20, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25389256
7.
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
J Antimicrob Chemother
; 70(6): 1833-42, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724985
8.
Creatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study.
J Antimicrob Chemother
; 68(2): 404-8, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23109185
9.
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.
NPJ Vaccines
; 8(1): 147, 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775521
10.
Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial.
Front Immunol
; 12: 767370, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858423
11.
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Gastroenterol Hepatol
; 5(1): 31-41, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31607677
12.
Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.
Vaccines (Basel)
; 7(4)2019 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31703287
13.
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection.
AIDS
; 32(17): 2533-2545, 2018 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30289805
14.
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
PLoS One
; 13(4): e0195915, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29634751
15.
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
PLoS One
; 12(10): e0186602, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29065142
16.
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.
Lancet Infect Dis
; 15(7): 785-92, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26062880
17.
Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravir.
AIDS Res Hum Retroviruses
; 29(2): 235-41, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22916715
18.
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir.
AIDS
; 26(18): 2315-26, 2012 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23018438
19.
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Vaccine
; 29(46): 8309-16, 2011 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21907749
20.
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction.
AIDS
; 24(3): F1-9, 2010 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20009917